Opportunity Information: Apply for PA 11 231
Apply for PA 11 231
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Epidemiology of Drug Abuse (R21)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Jun 16, 2011 and posted on Jun 16, 2011.
- Applicants must submit their applications by Sep 7, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification) Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) County governments Small businesses For profit organizations other than small businesses Private institutions of higher education City or township governments State governments Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Native American tribal organizations (other than Federally recognized tribal governments).
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Epidemiology of Drug Abuse (R21) funding opportunity (PA 11-231) is a National Institutes of Health program announcement from the National Institute on Drug Abuse (NIDA) that uses the R21 exploratory/developmental grant mechanism to support early-stage or high-impact ideas in drug abuse epidemiology. The central purpose is to strengthen what is known about the nature and scope of drug use, abuse, and addiction, including where and among whom it occurs, why it develops, and what its downstream effects are. In practical terms, the FOA is aimed at projects that can improve understanding of the distribution, causes (etiology), and consequences of substance-related behaviors and disorders across individuals, families, communities, and diverse population groups.
A defining feature of this announcement is its preference for research that looks beyond a single cause or single level of explanation. NIDA explicitly encourages applications that address multiple levels of causation and reflect the broad reach of modern epidemiology. That can include work that links biological factors (such as genetic liability) with environmental exposures and developmental timing, or research that shows how social conditions and contexts shape drug-related risk and health outcomes. The FOA also emphasizes transdisciplinary approaches, meaning projects that integrate methods, theories, or data sources across fields (for example, combining epidemiology with genetics, developmental science, sociology, economics, data science, or health services research). Another strong emphasis is on novel methods that can move the science forward, such as innovative analytic strategies, creative study designs, or new ways of integrating multilevel data.
The program also highlights the value of cost-efficient research that leverages existing investments by NIH and other funders. Applicants are encouraged to use existing datasets, cohort resources, surveillance systems, administrative records, or other already-collected data in creative ways to answer important epidemiologic questions about drug abuse and addiction. This reflects a clear interest in maximizing scientific yield without necessarily requiring expensive new data collection, especially when strong inference can be achieved through thoughtful secondary analyses, data linkage, harmonization across studies, or innovative modeling.
From an administrative standpoint, this is a discretionary grant opportunity in the NIH/NIDA portfolio, categorized under education and health, with CFDA number 93.279 (Drug Abuse and Addiction Research Programs). The award ceiling listed is $200,000, and there is no cost sharing or matching requirement. The opportunity was posted and created on June 16, 2011, with an original and final closing date of September 7, 2014, and an archive date of October 8, 2014 (meaning it is no longer active, but it remains useful as a reference for the kinds of projects NIDA sought under this mechanism).
Eligibility is broad and includes many types of domestic U.S. organizations and governments, such as public and private institutions of higher education, nonprofits (with and without 501(c)(3) status), for-profit entities (including small businesses and other for-profits), and governmental units (state, county, city/township, special district governments), as well as public housing authorities/Indian housing authorities and independent school districts. The announcement also specifies additional eligible applicants, including faith-based and community-based organizations, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, regional organizations, eligible federal agencies, U.S. territories or possessions, and tribal governments and organizations (including categories beyond federally recognized tribal governments as noted). Importantly, foreign institutions are eligible to apply, non-U.S. components of U.S. organizations may apply, and foreign components are allowed as defined by NIH policy, which signals an openness to internationally focused or globally comparative epidemiology when it aligns with NIDA priorities.
For reference and official details, the FOA was hosted on the NIH Grants Guide website (link provided in the source: http://grants.nih.gov/grants/guide/pa-files/PA-11-231.html). The contact information included is primarily technical support through the NIH Office of Extramural Research (OER) webmaster for access or linking issues, rather than a scientific/program contact, which is typical for archived listings or summary records.
Frequently Asked Questions (FAQs): Epidemiology of Drug Abuse (R21) - PA 11-231
What is the Epidemiology of Drug Abuse (R21) funding opportunity (PA 11-231)?
PA 11-231 is a National Institutes of Health (NIH) program announcement from the National Institute on Drug Abuse (NIDA). It uses the R21 exploratory/developmental grant mechanism to support early-stage or potentially high-impact research ideas in drug abuse epidemiology.
Which NIH institute is sponsoring this announcement?
This program announcement is from the National Institute on Drug Abuse (NIDA), part of the NIH.
What grant mechanism does this opportunity use?
The opportunity uses the NIH R21 exploratory/developmental grant mechanism.
What is the central purpose of this FOA?
The central purpose is to strengthen what is known about the nature and scope of drug use, abuse, and addiction, including where and among whom it occurs, why it develops, and what downstream effects it has.
What types of research questions are a fit for this announcement?
Projects aimed at improving understanding of the distribution, causes (etiology), and consequences of substance-related behaviors and disorders across individuals, families, communities, and diverse population groups are a fit for this announcement.
Does NIDA prefer projects that examine multiple causes or levels of influence?
Yes. A defining feature of the announcement is a preference for research that looks beyond a single cause or a single level of explanation and instead addresses multiple levels of causation.
What does "multiple levels of causation" mean in the context of this FOA?
Within this FOA, it includes approaches that connect biological factors (such as genetic liability) with environmental exposures and developmental timing, and/or show how social conditions and contexts shape drug-related risk and health outcomes.
Is transdisciplinary research encouraged?
Yes. The FOA emphasizes transdisciplinary approaches that integrate methods, theories, or data sources across fields (for example, combining epidemiology with genetics, developmental science, sociology, economics, data science, or health services research).
Are novel methods and innovative designs explicitly encouraged?
Yes. The program emphasizes novel methods that can move the science forward, including innovative analytic strategies, creative study designs, or new ways of integrating multilevel data.
Does the FOA encourage using existing datasets or resources?
Yes. The FOA highlights cost-efficient research that leverages existing investments and encourages using existing datasets, cohort resources, surveillance systems, administrative records, or other already-collected data in creative ways.
What are examples of cost-efficient approaches mentioned in the announcement?
Examples include thoughtful secondary analyses, data linkage, harmonization across studies, and innovative modeling using already-collected data or established resources.
What is the award ceiling listed for this opportunity?
The listed award ceiling is $200,000.
Is cost sharing or matching required?
No. The opportunity specifies that there is no cost sharing or matching requirement.
How is this opportunity categorized administratively?
It is described as a discretionary grant opportunity in the NIH/NIDA portfolio and is categorized under education and health.
What is the CFDA number associated with this program?
The CFDA number listed is 93.279, Drug Abuse and Addiction Research Programs.
When was this opportunity posted and created?
The opportunity was posted and created on June 16, 2011.
What were the closing dates for applications?
The original closing date and the final closing date were both September 7, 2014.
Is this funding opportunity still active?
No. The archive date is October 8, 2014, which indicates the opportunity is no longer active and is maintained as an archived reference.
Who is eligible to apply (in general terms)?
Eligibility is broad and includes many types of U.S. organizations and governments, as well as foreign institutions and foreign components as allowed under NIH policy.
Which U.S. organization types are eligible?
Eligible applicants include public and private institutions of higher education; nonprofits (with and without 501(c)(3) status); for-profit entities (including small businesses and other for-profits); and government entities such as state, county, city/township, and special district governments.
Are public housing authorities and independent school districts eligible?
Yes. Public housing authorities/Indian housing authorities and independent school districts are listed as eligible applicants.
Are faith-based and community-based organizations eligible?
Yes. The announcement specifies that faith-based and community-based organizations are included among eligible applicants.
Are minority-serving institutions specifically mentioned as eligible?
Yes. The announcement lists multiple categories, including Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), and Alaska Native and Native Hawaiian-serving institutions.
Are tribal governments and tribal organizations eligible?
Yes. Tribal governments and organizations are included in the eligibility list, including categories beyond federally recognized tribal governments as noted in the announcement summary.
Are U.S. territories or possessions eligible?
Yes. U.S. territories or possessions are included among eligible applicants.
Are federal agencies eligible to apply?
Yes. The eligibility list includes eligible federal agencies.
Are foreign institutions eligible to apply?
Yes. The announcement states that foreign institutions are eligible to apply.
Can non-U.S. components of U.S. organizations apply?
Yes. Non-U.S. components of U.S. organizations may apply.
Are foreign components allowed under this FOA?
Yes. Foreign components are allowed as defined by NIH policy, indicating openness to internationally focused or globally comparative epidemiology when aligned with NIDA priorities.
Where can applicants find the official FOA details?
The FOA was hosted on the NIH Grants Guide website at: http://grants.nih.gov/grants/guide/pa-files/PA-11-231.html
What contact information is provided for this opportunity?
The contact information included is primarily technical support through the NIH Office of Extramural Research (OER) webmaster for access or linking issues, rather than a scientific or program contact.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: Epidemiology of Drug Abuse (R03)
Previous opportunity: Epidemiology of Drug Abuse (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 11 231
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 11 231) also looked into and applied for these:
| Funding Opportunity |
|---|
| Epidemiology of Drug Abuse (R03) Apply for PA 11 232 Funding Number: PA 11 232 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Probes for Microimaging The Nervous System (SBIR R43/R44) Apply for PA 09 062 Funding Number: PA 09 062 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 11 231", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.